Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 42-46, January 2010

Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation

Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands

Received 17 June 2009; received in revised form 27 October 2009; accepted 29 November 2009. published online 21 December 2009.

Abstract 

Purpose

To define a method of dose prescription employing Monte Carlo (MC) dose calculation in stereotactic body radiotherapy (SBRT) for lung tumours aiming at a dose as low as possible outside of the PTV.

Methods and materials

Six typical T1 lung tumours – three small, three large – were constructed centrally, peripherally in the lung, and nearby the thoracic wall, respectively. For each of these, five treatment plans employing dynamic conformal arc technique were made in which the dose was prescribed to encompass the PTV with the prescription isodose level (PIL) set in a range between 50% and 80% of the isocenter dose. Three shells of respectively 10mm thickness around the PTV were constructed to assess the dose in the tissues directly adjacent to the PTV.

Results

The PTV was nicely covered (mean 98.8%±0.9%) with favourable conformity indices (mean 1.09±0.1). Mean doses around the PTVs were 73% (±1.3%), 76% (±3.5%), and 85% (±5.1%) of the prescribed dose in shell 1 for PIL50%, PIL65%, and PIL80%, respectively; 40% (±2.6%), 44% (±5.1%), 54% (±9.3%) in shell 2; and 24% (±1.9%), 26% (±3.6%), 33% (±6.8%) in shell 3. All normal tissue doses including the integral dose were also consistently worst for PIL80%. Monitor units were 30% higher for PIL65%, and 70% higher for PIL50%, compared with PIL80%.

Conclusions

To improve normal tissue sparing the dose should be prescribed at an isodose lower than 80% of the isocenter dose in SBRT when using conformal arc technique with MC dose calculation.

Keywords: Dose prescription, Lung, Monte Carlo dose calculation, Stereotactic body radiotherapy, Stereotactic radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00647-1

doi:10.1016/j.radonc.2009.11.008

Radiotherapy & Oncology
Volume 94, Issue 1 , Pages 42-46, January 2010